U.S. authorizes Johnson & Johnson's COVID-19 vaccine
Approval of the single-dose vaccine will enable millions more Americans to get shots in coming weeks and will set it up for additional approvals. Few serious side effects were reported in a global trial, which also suggested that the vaccine reduced asymptomatic infections.